Your Article Summary
Current management of erectile dysfunction after cancer treatment
Current Opinion in Oncology, 06/12/09
Peltier A et al. - Erectile dysfunction postcancer treatment requires multimodal management with early administration of PDE5-Is, combined therapy to maintain erectile tissue oxygenation if necessary with PDE5-Is, intracavernosal injection and transurethral alprostadil or even vacuum erect device, psychological counseling considering erectile dysfunction as a couple's issue. The best modality to optimize postcancer erectile dysfunction management has not yet been standardized and is still challenging.
Related Articles
Hormonal Testing and Pharmacologic Treatment of Erectile Dysfunction: A Clinical Practice Guideline From the American College of Physicians
Annals of Internal Medicine, 10/30/09
Relevance Score: 70%
Effects of 12-Month Tadalafil Therapy for Erectile Dysfunction on Couple Relationships: Results from the DETECT Study
The Journal of Sexual Medicine, 10/28/09
Relevance Score: 69%
Evaluation of Microalbuminuria in Patients with Erectile Dysfunction
The Journal of Sexual Medicine, 10/07/09
Relevance Score: 69%
New Drug Udenafil for Erectile Dysfunction in US Trials
Internet Source, 11/10/09
Relevance Score: 68%
The Association of Serum Prolidase Activity and Erectile Dysfunction
Journal of Andrology, 10/23/09
Relevance Score: 68%
Today in Erectile Dysfunction...keeping you current
Receive free subspecialty "5-minute updates" via email
The association between erectile dysfunction and peripheral arterial disease as determined by screening ankle-brachial index testing
Atherosclerosis, 12/04/09
Effect of transurethral resection of the prostate on erectile function: a prospective comparative study
International Journal of Impotence Research, 12/02/09
Erectile dysfunction in severe sleep apnea patients and response to CPAP
International Journal of Impotence Research, 12/02/09

See Latest Articles